157 related articles for article (PubMed ID: 12707351)
21. Hierarchical recognition of CpG motifs expressed by immunostimulatory oligodeoxynucleotides.
Klinman DM; Currie D
Clin Exp Immunol; 2003 Aug; 133(2):227-32. PubMed ID: 12869028
[TBL] [Abstract][Full Text] [Related]
22. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
Hartmann G; Weeratna RD; Ballas ZK; Payette P; Blackwell S; Suparto I; Rasmussen WL; Waldschmidt M; Sajuthi D; Purcell RH; Davis HL; Krieg AM
J Immunol; 2000 Feb; 164(3):1617-24. PubMed ID: 10640783
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding.
Nichani AK; Mena A; Kaushik RS; Mutwiri GK; Townsend HG; Hecker R; Krieg AM; Babiuk LA; Griebel PJ
Oligonucleotides; 2006; 16(1):58-67. PubMed ID: 16584295
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8
Policicchio BB; Cardozo EF; Sette P; Xu C; Haret-Richter G; Dunsmore T; Apetrei C; Pandrea I; Ribeiro RM
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643246
[TBL] [Abstract][Full Text] [Related]
26. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses.
Marthas ML; Lu D; Penedo MC; Hendrickx AG; Miller CJ
AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1455-66. PubMed ID: 11679158
[TBL] [Abstract][Full Text] [Related]
27. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
Barrier M; Lacroix-Lamandé S; Mancassola R; Auray G; Bernardet N; Chaussé AM; Uematsu S; Akira S; Laurent F
J Infect Dis; 2006 May; 193(10):1400-7. PubMed ID: 16619188
[TBL] [Abstract][Full Text] [Related]
28. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in weaned piglets.
Zhang L; Tian X; Zhou F
Int Immunopharmacol; 2006 Oct; 6(10):1623-31. PubMed ID: 16919835
[TBL] [Abstract][Full Text] [Related]
29. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.
Juffermans NP; Leemans JC; Florquin S; Verbon A; Kolk AH; Speelman P; van Deventer SJ; van der Poll T
Infect Immun; 2002 Jan; 70(1):147-52. PubMed ID: 11748176
[TBL] [Abstract][Full Text] [Related]
30. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis.
Shargh VH; Jaafari MR; Khamesipour A; Jaafari I; Jalali SA; Abbasi A; Badiee A
Vaccine; 2012 Jun; 30(26):3957-64. PubMed ID: 22465747
[TBL] [Abstract][Full Text] [Related]
31. Safety of CpG oligodeoxynucleotides in veterinary species.
Ioannou XP; Griebel P; Mena A; Gomis SM; Godson DL; Mutwiri G; Hecker R; Babiuk LA; van Drunen Littel-van den Hurk S
Antisense Nucleic Acid Drug Dev; 2003; 13(3):157-67. PubMed ID: 12954116
[TBL] [Abstract][Full Text] [Related]
32. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
[TBL] [Abstract][Full Text] [Related]
33. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.
Klinman DM; Xie H; Ivins BE
Ann N Y Acad Sci; 2006 Oct; 1082():137-50. PubMed ID: 17145935
[TBL] [Abstract][Full Text] [Related]
34. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response.
Weighardt H; Feterowski C; Veit M; Rump M; Wagner H; Holzmann B
J Immunol; 2000 Oct; 165(8):4537-43. PubMed ID: 11035094
[TBL] [Abstract][Full Text] [Related]
35. CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
Thacker SG; McWilliams IL; Bonnet B; Halie L; Beaucage S; Rachuri S; Dey R; Duncan R; Modabber F; Robinson S; Bilbe G; Arana B; Verthelyi D
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008050. PubMed ID: 32109251
[TBL] [Abstract][Full Text] [Related]
36. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'.
Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516
[TBL] [Abstract][Full Text] [Related]
37. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
[TBL] [Abstract][Full Text] [Related]
38. The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice.
Alavizadeh SH; Badiee A; Khamesipour A; Jalali SA; Firouzmand H; Abbasi A; Jaafari MR
Exp Parasitol; 2012 Nov; 132(3):313-9. PubMed ID: 22819791
[TBL] [Abstract][Full Text] [Related]
39. Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques.
Hensley-McBain T; Zevin AS; Manuzak J; Smith E; Gile J; Miller C; Agricola B; Katze M; Reeves RK; Kraft CS; Langevin S; Klatt NR
J Virol; 2016 May; 90(10):4981-4989. PubMed ID: 26937040
[TBL] [Abstract][Full Text] [Related]
40. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
Lee SW; Song MK; Baek KH; Park Y; Kim JK; Lee CH; Cheong HK; Cheong C; Sung YC
J Immunol; 2000 Oct; 165(7):3631-9. PubMed ID: 11034366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
